Revised February 2018
Opioid-Related Overdose Deaths
In 2016, there were 914 opioid-related overdose deaths in Missouri—a rate of 15.9 deaths per 100,000 persons—compared to the national rate of 13.3 deaths per 100,000 persons. From 2012 to 2016 heroin overdose deaths increased from 210 to 380 deaths. Synthetic opioid overdose deaths have been increasing dramatically since 2013 from 97 to 441 deaths.
Opioid Pain Reliever Prescriptions
In 2015, Missouri providers wrote 90 opioid prescriptions per 100 persons (5.2 million prescriptions). In the same year, the average U.S. rate was 70 opioid prescriptions per 100 persons (IMS Health, 2016).
Neonatal Abstinence Syndrome (NAS)
A CDC study analyzing 2013 NAS data available across 28 states estimated the national average NAS rate at 0.6 percent of live births (CDC, MMWR, 2014). In Missouri, a review of hospital diagnostic codes for all births between 2006 and 2016 found a more than fivefold increase in codes related to NAS stemming from maternal drug use (See bottom figure, MO Hospital Association).
HIV Prevalence and HIV Diagnoses Attributed to Injection Drug Use (IDU)
- U.S. Incidence: In 2015, 9.1 percent (3,5941) of the 39,513 new diagnoses of HIV in the United States were attributed to IDU. Among new cases, 8.2 percent (2,6141) of cases among men and 13.2 percent (980) of cases among women were transmitted via IDU (CDC).
- U.S. Prevalence: In 2014, 955,081 Americans were living with a diagnosed HIV infection—a rate of 299.5 per 100,000 persons. Of these, 18.1 percent (131,0561) of males and 22.6 percent (52,013) of females were living with HIV attributed to IDU (CDC).
- State Incidence: Of the new HIV cases in 2015, 465 occurred in Missouri, with 8.1 percent1 of new cases in males and 10.1 percent of new cases in females attributed to IDU (AIDSVu).
- State Prevalence: In 2014, an estimated 11,560 persons were living with a diagnosed HIV infection in Missouri—a rate of 228 infections per 100,000 persons. Of these, 13.5 percent1 of males and 16.6 percent of females were living with HIV attributed to IDU (AIDSVu).
Hepatitis C (HCV) Prevalence and HCV Diagnoses Attributed to Injection Drug Use
- U.S. Incidence: In 2015, there were 181,871 reported cases of chronic HCV and 33,900 estimated cases of acute HCV2 (CDC). Where data were available, 64.2 percent of acute cases reported IDU (CDC).
- U.S. Prevalence: An estimated 3.5 million Americans are living with HCV, including approximately 2.7 million living with chronic infections (CDC).
- State Incidence: In 2015, Missouri reported a total of 7,803 HCV cases (7,795 chronic and 8 acute) at a rate of 128.7 cases per 100,000 persons (MO.gov).
- State Prevalence: Current state prevalence data are not available. As of 2010, an estimated 76,900 (1,690 per 100,000) persons were living with HCV in Missouri (HepVu).
- Missouri Department of Health and Senior Services, Missouri Opioids Information and Opioid Crisis Response
- Centers for Disease Control and Prevention, Opioid Overdose
- Centers for Disease Control and Prevention, Annual Surveillance Report of Drug-Related Risks and Outcomes (2017)
- Substance Abuse and Mental Health Services Administration, Behavioral Health Barometer Missouri, Volume 4 (2017)
- Includes transmission to individuals with injection drug use as a risk factor.
- 2015 estimate after adjusting for under-ascertainment and under-reporting. Data for 2015 were unavailable for Alaska, Arizona, Connecticut, the District of Columbia, Hawaii, Iowa, Mississippi, New Hampshire, Rhode Island, and Wyoming.
Emerging Trends & Alerts
Get more information on Emerging Trends and Alerts, we will update this page with the latest research findings as they develop.
Get this Publication
NIH HEAL (Helping to End Addiction Long-term) Initiative
New Opioid Overdose Materials for Patients
Find information about addiction and mental health services in your area. You can search by state or zip code online or call the number. (SAMHSA)